CEI
Clark Estates Inc Portfolio holdings
AUM
$446M
This Quarter Return
-1.4%
1 Year Return
+6.99%
3 Year Return
+36.03%
5 Year Return
+102.21%
10 Year Return
+152.93%
AUM
$446M
AUM Growth
+$446M
(-5.6%)
Cap. Flow
-$15.9M
Cap. Flow
% of AUM
-3.57%
Top 10 Holdings %
Top 10 Hldgs %
59.7%
Holding
108
New
14
Increased
10
Reduced
10
Closed
11
Top Buys
| 1 |
Walt Disney
DIS
|
$15.5M |
| 2 |
IQVIA
IQV
|
$9.46M |
| 3 |
Fiserv
FI
|
$7.76M |
| 4 |
United Parks & Resorts
PRKS
|
$6.13M |
| 5 |
Bausch + Lomb
BLCO
|
$2.97M |
Top Sells
| 1 |
DNB
Dun & Bradstreet
DNB
|
$23.9M |
| 2 |
Philip Morris
PM
|
$7.98M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
$7.04M |
| 4 |
Smith & Nephew
SNN
|
$5.36M |
| 5 |
Sony
SONY
|
$5.21M |
Sector Composition
| 1 | Healthcare | 36.1% |
| 2 | Consumer Staples | 12.26% |
| 3 | Technology | 11.71% |
| 4 | Communication Services | 7.47% |
| 5 | Consumer Discretionary | 6.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Euclidean Fundamental Value ETF
ECML
$134M
| $95M | 21.32% | 3,085,507 -66,189 | -2% | -$2.04M |
|
|
2
IQVIA
IQV
$32.4B
| $24.5M | 5.49% | 155,200 +60,000 | +63% | +$9.46M |
|
3
Baxter International
BAX
$12.7B
| $24.4M | 5.47% | 805,000 +55,000 | +7% | +$1.67M |
|
4
Medtronic
MDT
$119B
| $21.8M | 4.89% | 250,000 | – | – |
|
|
5
Smith & Nephew
SNN
$16.3B
| $20.7M | 4.64% | 675,000 -175,000 | -21% | -$5.36M |
|
6
Kenvue
KVUE
$39.7B
| $18.8M | 4.23% | 900,000 +50,000 | +6% | +$1.05M |
|
7
Haleon
HLN
$43.9B
| $18.7M | 4.19% | 1,800,000 -200,000 | -10% | -$2.07M |
|
|
8
Walt Disney
DIS
$213B
| $15.5M | 3.48% | +125,000 | New | +$15.5M |
|
9
Diageo
DEO
$62.1B
| $14.6M | 3.28% | 145,000 -40,000 | -22% | -$4.03M |
|
|
10
Fiserv
FI
$75.1B
| $12.1M | 2.72% | 70,300 +45,000 | +178% | +$7.76M |
|
|
11
Bausch + Lomb
BLCO
$5.18B
| $11.1M | 2.48% | 850,000 +228,000 | +37% | +$2.97M |
|
12
Unilever
UL
$155B
| $11M | 2.47% | 180,000 -55,000 | -23% | -$3.36M |
|
|
13
Sony
SONY
$165B
| $10.4M | 2.34% | 400,000 -200,000 | -33% | -$5.21M |
|
|
14
United Parks & Resorts
PRKS
$2.89B
| $6.13M | 1.38% | +130,000 | New | +$6.13M |
|
15
Avanos Medical
AVNS
$554M
| $6.05M | 1.36% | 493,880 | – | – |
|
16
Heidrick & Struggles
HSII
$1.05B
| $3.08M | 0.69% | 67,387 | – | – |
|
17
Indivior
INDV
$3.03B
| $3M | 0.67% | 203,600 +17,325 | +9% | +$255K |
|
18
Gilead Sciences
GILD
$140B
| $2.89M | 0.65% | 26,022 | – | – |
|
19
Altria Group
MO
$113B
| $2.85M | 0.64% | 48,613 | – | – |
|
20
Nextracker
NXT
$9.95B
| $2.71M | 0.61% | 49,818 -8,800 | -15% | -$478K |
|
21
John Wiley & Sons Class A
WLY
$2.16B
| $2.56M | 0.57% | 57,252 | – | – |
|
22
Catalyst Pharmaceutical
CPRX
$2.52B
| $2.47M | 0.55% | 113,918 -20,500 | -15% | -$445K |
|
23
Pediatrix Medical
MD
$1.5B
| $2.46M | 0.55% | 171,313 -33,300 | -16% | -$478K |
|
24
Resideo Technologies
REZI
$5.07B
| $2.41M | 0.54% | 109,100 | – | – |
|
25
Incyte
INCY
$16.5B
| $2.38M | 0.53% | 34,952 | – | – |
|